Queen Mary University of London
Whole-Genome Sequencing Can Diagnose Neurological Repeat Expansion Disorders, UK Study Finds
The study involved researchers from Queen Mary University of London, University College London, Illumina, and Genomics England and NHS England.
Exagen, QMUL to Develop Molecular Signatures for Rheumatoid Arthritis Therapy Selection
The assays under development will segment patients according to gene expression in their synovial tissue biopsies to personalize therapy selection.
Study investigators found that patients with ctDNA-positive results after surgery were at higher risk of bladder cancer recurrence than those who were ctDNA-negative.
UK Government Partners With More Labs to Lift COVID-19 Testing Capacity
Laboratories at University College London, Imperial College London, Queen Mary University of London, and King's College London will all contribute to the effort.
BRCA1/2 Population Screening Predicted to be Cost-Effective in Countries With Different Income Levels
An analysis of societal and health system cost-effectiveness and outcomes points to the benefits of expanding pathogenic BRCA1/2 variant testing in six countries.